# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA3796922 | F | Antiviral activity against Enterovirus 71 infected in human RD cells assessed as cell viability after 3 days by MTS assay | Enterovirus A71 | 31 | ALA3792372 | organism-based format | Scientific Literature | |
2. | ALA3796923 | A | Cytotoxicity against human RD cells | Homo sapiens | 31 | ALA3792372 | cell-based format | Scientific Literature | |
3. | ALA3796924 | T | Selectivity index, ratio of CC50 for human RD cells to EC50 for Enterovirus 71 | 31 | ALA3792372 | cell-based format | Scientific Literature | ||
4. | ALA3796925 | F | Antiviral activity against Enterovirus 71 clinical isolate 11316 infected in human RD cells assessed as cell viability after 3 days by MTS assay | Enterovirus A71 | 2 | ALA3792372 | organism-based format | Scientific Literature | |
5. | ALA3796926 | F | Antiviral activity against Enterovirus 71 clinical isolate TW/96016/08 infected in human RD cells assessed as cell viability after 3 days by MTS assay | Enterovirus A71 | 2 | ALA3792372 | organism-based format | Scientific Literature | |
6. | ALA3796927 | F | Antiviral activity against Enterovirus 71 clinical isolate TW/70902/08 infected in human RD cells assessed as cell viability after 3 days by MTS assay | Enterovirus A71 | 2 | ALA3792372 | organism-based format | Scientific Literature | |
7. | ALA3796928 | F | Antiviral activity against Enterovirus 71 clinical isolate H08300 461#812 infected in human RD cells assessed as cell viability after 3 days by MTS assay | Enterovirus A71 | 2 | ALA3792372 | organism-based format | Scientific Literature | |
8. | ALA3796929 | F | Antiviral activity against Enterovirus 71 clinical isolate TW/1956/05 infected in human RD cells assessed as cell viability after 3 days by MTS assay | Enterovirus A71 | 2 | ALA3792372 | organism-based format | Scientific Literature | |
9. | ALA3796930 | F | Antiviral activity against Enterovirus 71 isolate TW/2429/04 infected in human RD cells assessed as cell viability after 3 days by MTS assay | Enterovirus A71 | 2 | ALA3792372 | organism-based format | Scientific Literature | |
10. | ALA3997014 | F | Antiviral activity against TEBV Absettarov infected in PEK cells assessed as inhibition of viral reproduction at 50 uM preincubated with virus for 1 hr followed by addition to PEK cells measured after 1 hr by gentian violet staining based plaque reduction assay relative to control | Tick-borne encephalitis virus | 31 | ALA3994636 | cell-based format | Scientific Literature | |
11. | ALA3997015 | F | Antiviral activity against TEBV Absettarov infected in PEK cells assessed as inhibition of viral reproduction preincubated with virus for 1 hr followed by addition to PEK cells measured after 1 hr by gentian violet staining based plaque reduction assay | Tick-borne encephalitis virus | 31 | ALA3994636 | cell-based format | Scientific Literature | |
12. | ALA3997016 | A | Cytotoxicity against PEK cells after 24 hrs | Sus scrofa | 31 | ALA3994636 | cell-based format | Scientific Literature | |
13. | ALA3997017 | A | Cytotoxicity against PEK cells after 7 days | Sus scrofa | 31 | ALA3994636 | cell-based format | Scientific Literature |